SHSE:688198 (China)
Â
Class A
Â¥
111.10
(-1.34%)
Dec 24
Business Description
Beijing Balance Medical Technology Co Ltd
ISIN : CNE100005X15
Share Class Description:
SHSE:688198: Class ACompare
Compare
Traded in other countries / regions
688198.China IPO Date
2019-12-09Description
Beijing Balance Medical Technology Co Ltd is engaged in the research and development and production of animal-derived implantable medical devices. The company's products are used in heart valve replacement and repair, congenital heart disease implant intervention and surgical soft tissue repair.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 23.61 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.1 | |||||
| Interest Coverage | 165.85 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 81.72 | |||||
| Beneish M-Score | -1.83 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 25.8 | |||||
| 3-Year EBITDA Growth Rate | 34.1 | |||||
| 3-Year EPS without NRI Growth Rate | 35.3 | |||||
| 3-Year FCF Growth Rate | -34.3 | |||||
| 3-Year Book Growth Rate | 12 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 40.09 | |||||
| Future 3-5Y Total Revenue Growth Rate | 33.28 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.78 | |||||
| 9-Day RSI | 28.74 | |||||
| 14-Day RSI | 36.33 | |||||
| 6-1 Month Momentum % | 13.56 | |||||
| 12-1 Month Momentum % | -1.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.99 | |||||
| Quick Ratio | 8.22 | |||||
| Cash Ratio | 3.85 | |||||
| Days Inventory | 334.28 | |||||
| Days Sales Outstanding | 75.44 | |||||
| Days Payable | 334.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.71 | |||||
| Dividend Payout Ratio | 1.02 | |||||
| 3-Year Dividend Growth Rate | 51.8 | |||||
| Forward Dividend Yield % | 0.71 | |||||
| 5-Year Yield-on-Cost % | 0.71 | |||||
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | 0.67 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.03 | |||||
| Operating Margin % | 21.8 | |||||
| Net Margin % | 25.53 | |||||
| FCF Margin % | -27.97 | |||||
| ROE % | 8.83 | |||||
| ROA % | 8.03 | |||||
| ROIC % | 9.09 | |||||
| ROC (Joel Greenblatt) % | 21.31 | |||||
| ROCE % | 8.49 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 146.18 | |||||
| Forward PE Ratio | 77.7 | |||||
| PE Ratio without NRI | 142.25 | |||||
| Price-to-Owner-Earnings | 649.71 | |||||
| PEG Ratio | 13.42 | |||||
| PS Ratio | 37.28 | |||||
| PB Ratio | 13.02 | |||||
| Price-to-Tangible-Book | 14.64 | |||||
| Price-to-Operating-Cash-Flow | 261.41 | |||||
| EV-to-EBIT | 146.93 | |||||
| EV-to-EBITDA | 146.93 | |||||
| EV-to-Revenue | 37.53 | |||||
| EV-to-FCF | -138.35 | |||||
| Price-to-Projected-FCF | 15.67 | |||||
| Price-to-Peter-Lynch-Fair-Value | 12.39 | |||||
| Price-to-Graham-Number | 9.62 | |||||
| Price-to-Net-Current-Asset-Value | 31.65 | |||||
| Price-to-Net-Cash | 106.83 | |||||
| Earnings Yield (Greenblatt) % | 0.68 | |||||
| FCF Yield % | -0.74 | |||||
| Forward Rate of Return (Yacktman) % | 11.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Balance Medical Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 405.571 | ||
| EPS (TTM) (Â¥) | 0.76 | ||
| Beta | 1.05 | ||
| Volatility % | 39.56 | ||
| 14-Day RSI | 36.33 | ||
| 14-Day ATR (Â¥) | 3.289326 | ||
| 20-Day SMA (Â¥) | 117.8835 | ||
| 12-1 Month Momentum % | -1.69 | ||
| 52-Week Range (Â¥) | 92.55 - 166 | ||
| Shares Outstanding (Mil) | 137.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Balance Medical Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Balance Medical Technology Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Balance Medical Technology Co Ltd Frequently Asked Questions
What is Beijing Balance Medical Technology Co Ltd(SHSE:688198)'s stock price today?
The current price of SHSE:688198 is ¥111.10. The 52 week high of SHSE:688198 is ¥166.00 and 52 week low is ¥92.55.
When is next earnings date of Beijing Balance Medical Technology Co Ltd(SHSE:688198)?
The next earnings date of Beijing Balance Medical Technology Co Ltd(SHSE:688198) is .
Does Beijing Balance Medical Technology Co Ltd(SHSE:688198) pay dividends? If so, how much?
The Dividend Yield %  of Beijing Balance Medical Technology Co Ltd(SHSE:688198) is 0.71% (As of Today), Highest Dividend Payout Ratio of Beijing Balance Medical Technology Co Ltd(SHSE:688198) was 1.02. The lowest was 0.47. And the median was 0.6. The  Forward Dividend Yield % of Beijing Balance Medical Technology Co Ltd(SHSE:688198) is 0.71%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers